Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02926417 · ClinicalTrials.gov registry record
Interventions for Postoperative Delirium: Biomarker-2 (IPOD-B2)
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 32
- Enrollment target
NCT02926417 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 32 participants.
The verdict
NCT02926417 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The IPOD-B2 Study aims to understand the pathogenesis of postoperative delirium in patients undergoing major surgery. The investigators will identify then correlate soluble biomarkers in blood and cerebral spinal fluid with changes in High Density-Electroencephalogram.
Interventions
- PROCEDURE High Density-Electroencephalogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-06 |
| Est. Completion | 2019-11-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02926417
The ClinicalTrials.gov registry entry for NCT02926417 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which High Density-Electroencephalogram is the first listed.
NCT02926417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02926417 about?
NCT02926417 is a clinical study titled "Interventions for Postoperative Delirium: Biomarker-2 (IPOD-B2)". The IPOD-B2 Study aims to understand the pathogenesis of postoperative delirium in patients undergoing major surgery. The investigators will identify then correlate soluble biomarkers in blood and cerebral spinal fluid with changes in High Density-Electroencephalogram.
What is the current status of trial NCT02926417?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2016-06. Estimated completion is 2019-11-26.
What interventions are being tested in trial NCT02926417?
The interventions under investigation include: High Density-Electroencephalogram (PROCEDURE).
Who is sponsoring clinical trial NCT02926417?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.